The combination of testosterone and dutasteride is intended for use in hypogonadal men. This study will evaluate the bioavailability and pharmacokinetics of various doses of testosterone administered with and without dutasteride
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
60
GSK Investigational Site
Tacoma, Washington, United States
lab tests for relative bioavailability of testosterone and dutasteride,
Time frame: days 1, 2, 3, 19, 20, 21 & 26-31
safety lab tests of various testosterone/dutasteride formulations,
Time frame: days 1, 2, 3, 19, 20, 21 & 26-31.
lab tests for additional pharmacokinetic parameters for testosterone & dutasteride,
Time frame: days 1, 2, 3, 19, 20, 21 & 26-31.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.